CapsoVision (NASDAQ:CV) Shares Down 6.5% – Time to Sell?

CapsoVision, Inc. (NASDAQ:CV)’s share price traded down 6.5% on Friday . The stock traded as low as $12.90 and last traded at $12.98. 11,088 shares were traded during trading, a decline of 93% from the average session volume of 163,197 shares. The stock had previously closed at $13.88.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on CV. Zacks Research raised CapsoVision to a “hold” rating in a report on Wednesday, November 5th. Roth Capital set a $7.00 price target on CapsoVision in a research report on Tuesday, November 4th. Benchmark reaffirmed a “speculative buy” rating on shares of CapsoVision in a research report on Friday, November 14th. Finally, Weiss Ratings reissued a “sell (e)” rating on shares of CapsoVision in a report on Monday, December 22nd. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $6.00.

CapsoVision Price Performance

The business has a 50 day simple moving average of $7.35.

CapsoVision (NASDAQ:CV) last posted its quarterly earnings results on Thursday, November 13th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.03). The business had revenue of $3.54 million during the quarter.

Institutional Trading of CapsoVision

A hedge fund recently bought a new stake in CapsoVision stock. New York State Common Retirement Fund acquired a new stake in CapsoVision, Inc. (NASDAQ:CV) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 7,114 shares of the company’s stock, valued at approximately $34,000.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.